Project Details
| Status | Active |
|---|---|
| Effective start/end date | 06/1/18 → … |
Funding
- Novo Nordisk-Industry/For Profit: $481,321.00
To Predict Weight Loss Response to Liraglutide (Saxenda®), from fMRI-based Determination of Food Cue Reactivity
- Dhurandhar, Nik (CoI)
- Binks, Martin (CoI)
- Dhurandhar, Nik (Other)
- Binks, Martin (Other)